health corp expert
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
i concur with your opinion. If someone knew something the volume would be several hundred thousand or low millions. I think only $5,000 or $6,000 of spending . Suggests nothing.
yes, agree with all you say. the technical thing on flag and cross is hilarious.... is only important if someone is day trading hoping to gain a penny or two.
The prospect of revenue is all we need to get it started. group/company signing on to use the platform gives us the prospect/certainty of revenue.
News of an agreement will get us moving. and if it's a group that manages for example 200,000 diabetes patients then we can estimate future revenue from this single agreement............but understand there will be many, many more.
LastOne, I agree with you. He's harmless. But-We need few fruitcakes to make things interesting and laughable.
well described LastOne......yes, ALRT solves that problem. Selfcare does not work. Given the sweet valuation that Livongo has and given the ALRT Solution enables the healthcare providers and payers to manage large populations, with many more important benefits provided, I see the REAL value of ALRT to be 4 to 5 times greater than Livongo. Now, the stock analysts(wall street) need to have understanding and ALRT needs to begin signing agreements and we should see rapid rise in PPS and valuation.
I'm thinking it will begin happening within 30 to 45 days
good post
LOL------good one
its matter of perspective. To me, creeping up is from .04 to .25, to .40 to .75 then maybe it takes off from there.
This week or next week in the next few months is fine. To me, it doesn't matter if the PPS now is 03. .04, .09. Volume is nothing until several hundred thousand or so per day with price above .25. First commercial should get it stable at .30 and a second commercial news should get it to .50. I've been a shareholder for fifteen yrs plus. I certainly believe in the product/system they have developed. Do I expect a commercial corp to buy in to it? absolutely.......I worked on both sides of the equation in the diabetes market for many yrs.
marketing agreements are good but they do not represent a company that has decided to use the product. We want demand from the health groups who will use, recognition of benefit and value to those who will use it. I'm feeling good about the progress on this front.
Sure, marketing agreements will help the company avoid hiring a sales force. They will need a few high level sales personal for national or large company accounts as well as trainers to "train the trainer".
One caveat in marketing agreements is who it's with. If they sign a co-marketing agreement with one of the mega insulin manufacturers then the stock price goes through any level of roof you choose to demolish.
that would be 20,000 users....and all could come from one customer. ALRT is B to B. Once they get a few customers signed on, I personally expect several hundred thousand users in first year.........if not more. One health care group, or one health insurance company or one large self insured alone could represent a few hundred thousand users.....or much more.
it could go up to .08 and that is still not budging. Must be .20 or more before it's a move of any consequence. But one dollar is the real target. Hope they find healthcare companies that see the value of their platform soon.. Would think many would want to pay for this service. Just so strange no biters yet. Yet I remain confident because I know healthcare market and clearly see the value.
jammamastermike; seriously, I suggest you contact Mr. Chan. If you have contacts in the healthcare market then I'm sure ALRT would gladly set you up to go after accounts. and I'm sure they would make it very lucrative for you. Their contact email is at the bottom of all press releases.
Pricing. Reimbursement. Yes, the bundling strategy is brilliant. It allows the self insured and govt health plans to provide the testing supplies and the ALRT services all for the same price as testing supplies alone. So consider this: govt plan plan has two choices. ONE: paying for glucometers and testing supplies. OR Second Choice: Paying the same amount for the same quality glucometers and test supplies and getting the ALRT services for NO EXTRA CHARGE. To me, the only possible hurdle is the logistics of implementation.......which if govt plan or self insured plan it should not be a problem.
AJ. A couple additional points which I believe will assure health insurers will sign:
The bundling strategy means that for no extra cost beyond what they currently pay on the reimbursement codes for glucose testing equipment and supplies, the Health plans that sign on, will get all the same best in class supplies and the ALRT Diabetes Solution platform services comes with it at no extra charge. Just think of the extra benefit of the remote management including the patented Predictive A1c and the FDA cleared Insulin dose adjustment. These services should really help get the diabetes patients to the necessary level of intense management on a timely basis. Its all included in the bundle. It's like buying a car from one dealer for the same price as the exact same car from another dealer, but you also get free maintenance for life. I don't see any reason for a health insurer to not go for the ALRT bundle. It's Brilliant.
I concur with you TonyJoe.
TJ, good points. What is happening with these?
thanks for missing me JohnG. LOL. Yes, we hold. This will be the year of significant PPS growth. I've always believed in the company's technology platform. The healthcare decision makers are finally coming round. They have admitted for the past several years that the ALRT technology would be good for patient outcome and cost effective (cost reductions) to the payers. It's all about adopting change, logistics for implementation and now that the ALRT platform is offered in the bundle, it's a brilliant move.
haha, you must be new to company evaluation. Early stage company value has nothing to do with revenue or balance sheet. It's all about the confidence level of future revenue and earnings.
i beg to differ. When the last FDA clearance was announced, over 40 million shares traded in one day, and several million above $0.12 a share. It's the fact that they will be restricted once the options are executed that matters to us. I doubt they would be executed for some time. and then there would be restriction from trading for some time period. and when they are executed it will put $230,000 cash into ALRT coffers. I and eleven friends own nearly 20 million shares between us. We analyze this company and market potential very carefully. We're confident of significant success. No thirty or forty cents a share for us. We're looking for the healthcare market to finally catch up to where ALR is and embrace it fully.
Agreed, it's all BS. this is just really funny----it's so stupid I do get a laugh out of it
Yes, hopefully any day now. Just wonder why after all this time we never hear about any company that wants to pay for this service. In the US, TPAs and hospitals likely do not want it because it reduces the need for care. TPAs need transactions and hospitals need beds filled. Thus, we need the payers like self insured corporations and govt plans---they have incentive with reduced costs.
I agree. I think the computer, or smart phone, issues were resolved long ago. It's so essential for the service. I do not think it's an issue at all.
maybe lastone will give Chan a call and get some info on this
this was included in press release when they signed on with 3 manufacturer suppliers of glucose testing equipment. ALRT will make five to ten $ per month per patient. This was such a brilliant move/strategy on part of Mr.Chan. For what Medicare pays on the test supplies for reimbursement ALRT can offer the supplies AND the ALRT platform patient management service.
Patient does not pay. and the insurance payor will pay no more than normal reimbursement for the supplies only.
So (I think this is how the youngsters start sentences), ALRT has a diabetes management platform that no other company can come close to matching. So, they offer it at no charge-----only at the same price that is paid for the test supplies.
So, you get the test supplies at market price and get the ALRT system free of charge. How can any disease management company turn this down. So, how can any health insurance payor turn this down. So, we all should be making lots of money very soon. The patient is better off. The health plan payor is better off. So, this is pretty cool.
last-one. It's been many months since the marketing partners were announced. I was thinking each would have done due diligence and knew they had customers in the ready. Been quite a long time given the platform has been market ready for some time. Interested in your take on this. I've been holding for several years.
Love it --- thanks AJ
yes......LOL, and the shares wouldn't be available at his bid price anyway.
yeah, great point. The ask price is so low it doesn't matter--- the price gets to $0.30 and above once news of sales contract is announced. IMO
when a company that plans to use the system with their patients signs on, that is when the PR should go out....and not wait until they have it actually in use. Implementation takes time. The PR would/should include the geographic area the company covers and the total number of diabetics they currently manage/treat. This is the potential from the single customer.
I thought we would have seen one by now, given all the news on marketing partners, and the news some time go bout Canada.
this will move fast, in .05 increments likely within a few minutes time, once news of customer signing on comes otu. IMO. I'm looking for $0.30 plus once the news of large customer comes out.
I've paid as $0.24 for this stock........and about 20 of my friends or business associates each own 300,000 shares or more. 4 or 5 own more than
a million.
you talking about alrt?
last one: Canada, shouldn't we expect news of use agreement there soon? Been several months.
Impressive, this company from Dubai will bring business in based on their influence. Yes, the same 20 countries that the PR stated. 40 million with diabetes.
today could be strong. the news is even better than the India news in my opinion. The Dubai company looks to be strong with incredible influence, connections and understanding of the value of technology solutions in diabetes management. I expect them to get usage and market growth soon.
news out
https://www.nasdaq.com/press-release/alr-technologies-and-ideas-dwc-llc-to-market-the-alrt-diabetes-solution-in-themiddle-east-and-nort-20181001-00470
ALR Technologies and IDEAS DWC LLC to Market the ALRT Diabetes Solution In the Middle East and North Africa
By GlobeNewswire, October 01, 2018, 08:00:00 AM EDT
ALRT's comprehensive diabetes management system could improve outcomes and provide diagnostic tools for diabetes therapies in one of the world's most critical diabetes markets
RICHMOND, Va., Oct. 01, 2018 (GLOBE NEWSWIRE) -- ALR Technologies Inc. (OTCPINK:ALRT) has signed a Collaboration Agreement with IDEAS DWC LLC. ("IDEAS"), a Dubai-based marketing company, to bring the ALRT Diabetes Solution to the estimated 40 million people with diabetes in the Middle East and North Africa (MENA) region. The International Diabetes Foundation reports that this regional area has the highest prevalence of diabetes in the world. The initial focus will be the Gulf Cooperation Council countries, specifically UAE, Saudi Arabia and Kuwait.
Under the terms of the agreement, IDEAS will conduct all business activities on behalf of ALRT in the region and ALRT will provide all necessary support to IDEAS.
Presentations have been made in Dubai to hospital and health groups and additional meetings are planned with Dubai and UAE health authorities.
"This agreement will give ALRT access to markets with growing diabetes prevalence through established professionals in the local markets," said Sidney Chan, Chairman and CEO of ALR Technologies Inc. "This will increase ALRT's marketing reach while helping to improve delivery of best practice diabetes care and patient outcomes in one of the world's most critical diabetes markets."
"With direct access to medical and health government authorities, close collaborations to more than 50 major medical chains and all major insurance companies in the region, IDEAS can advance ALRT's business to a new level." said Marian Han, Vice President of IDEAS DWC LLC.
MENA countries defined in the Collaboration Agreement include: Afghanistan, Algeria, Bahrain, Egypt, Iran, Iraq, Jordan, Kuwait, Lebanon, Libya, Morocco, Oman, Pakistan, Palestine, Qatar, Saudi Arabia, Sudan, Syria, United Arab Emirates and Yemen
About ALR Technologies Inc.
ALR Technologies is a medical device company that developed the ALRT Diabetes Solution, a comprehensive approach to diabetes care that includes: a FDA-cleared and HIPAA compliant diabetes management system that collects data directly from blood glucose meters; a patent pending Predicative A1C to track treatment success between lab reports; FDA-cleared Insulin Dosing Adjustment that suggests insulin dosing changes to optimize drug therapy; and, performance tracking to ensure best practices are followed. Currently, the Company is focused on diabetes and will expand its services to cover other chronic diseases anchored on verifiable data. More information about ALR Technologies, Inc. can be found at www.alrt.com.
About IDEAS DWC LLC
IDEAS DWC LLC (IDL) is a subsidiary of IGC (IDEAS Group of Companies) - a global investment group with portfolios in different regions with core business in asset management, resource collaborations and government advisory member. Located in Dubai, IDL is specialized in marketing and consulting with profound connections with different parties in the MENA region: royal families, government bodies, business conglomerates, celebrities, influencers and more. In medical and health industry, IDEAS has been evolving in projects bridging gaps of technology, products and the market with innovative business models and collaborations to leverage the powers and resources of different parties for multi-lateral success.
yes, wonderful news. This company has the connections and influence to bring in major customers soon in my opinion.
“to bring the ALRT Diabetes Solution to the estimated 40 million people with diabetes in the Middle East and North Africa (MENA) region”
“With direct access to medical and health government authorities, close collaborations to more than 50 major medical chains and all major insurance companies in the region, IDEAS can advance ALRT’s business to a new level.” said Marian Han, Vice President of IDEAS DWC LLC.
“Presentations have been made in Dubai to hospital and health groups and additional meetings are planned with Dubai and UAE health authorities.”
my apologies---mixed up with someone else.
let's focus on alrt